Clinical Trial

Single Ascending Doses (SAD) and Multiple Ascending Doses(MAD) Study of IG001119 in Healthy Adult Participants

Name: Single Ascending Doses (SAD) and Multiple Ascending Doses(MAD) Study of IG001119 in Healthy Adult Participants — clinical trial record (NCT07618247)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IG001119 in Healthy Participants

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-05-26.

Trial Details

NCT Number	NCT07618247
Lead Sponsor	Iongen Therapeutics Co., Ltd.
Conditions	Pain
Enrollment	64 participants
Start Date	2026-06-04
Primary Completion	2027-04-30 (estimated)
Study Completion	2027-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-03